The Future of Cell Therapy Manufacturing
True Walk-Away End-to-End Automation
Without compromising on process flexibility or process control.
Industrial Robot
Executes 10+ software-defined manufacturing workflows by moving closed cartridges from one bioprocessing instrument to the next.Integrated Cleanroom Environment
True HEPA filters and automated sterilization methods establish a cleanroom environment, allowing the solution to be deployed in lower class environments.QC Instruments
Automated sampling and integrated QC instruments generate rich in-process data.Bioprocessing Instruments
The instrument configuration is optimized to achieve throughput matching for our customer’s processes.Automated Feedthrough
Load GMP-in-a-box cartridges into the automated feedthrough to start up to 10+ independent cell therapy manufacturing workflows.Scalable
Ability to run 10+ processes simultaneously enables high-throughput process development in a scale-down model and commercial manufacturing in a scale-out model.
Closed & Automated
True walk-away end-to-end automation in a closed system enables 70% cost reduction and 3-fold reduction in process failure rates.
Process Control & Flexibility
Modular hardware and powerful software allow our customers to design and execute the processes that define their products.

Industrial Robot
Executes 10+ software-defined manufacturing workflows by moving closed cartridges from one bioprocessing instrument to the next.

Integrated Cleanroom Environment
True HEPA filters and automated sterilization methods establish a cleanroom environment, allowing the solution to be deployed in lower class environments.

QC Instruments
Automated sampling and integrated QC instruments generate rich in-process data.

Bioprocessing Instruments
The instrument configuration is optimized to achieve throughput matching for our customer’s processes.

Automated Feedthrough

Load GMP-in-a-box cartridges into the automated feedthrough to start up to 10+ independent cell therapy manufacturing workflows.
We Power the Future of Cell Therapy
Cellares brings a unique value proposition to its customers.

Meet Patient Demand
Scale out to tens of thousands of patient doses per year and provide access to life-saving cell therapies.

Lower Cost
Up to 70% lower manufacturing cost for most cell therapy workflows due to elimination of human labor and reduced cleanroom needs.

Accelerate Market Entry
Continuity of a single technology platform from preclinical to commercial stage accelerates market entry by 1-2 years.

Reduce Vein-to-Vein Time
End-to-end automation significantly reduces dwell time compared to manual methods which leads to shorter manufacturing processes.

Improve Process Control
Tight control over all process parameters results in highly reproducible manufacturing results.

Improve Robustness
Eliminating opportunities for operator error and contamination leads to a three-fold reduction in the risk of process failure.
We Power the Future of Cell Therapy
Cellares brings a unique value proposition to its customers.

Meet Patient Demand
Scale out to tens of thousands of patient doses per year and provide access to life-saving cell therapies.

Lower Cost
Up to 70% lower manufacturing cost for most cell therapy workflows due to elimination of human labor and reduced cleanroom needs.

Accelerate Market Entry
Continuity of a single technology platform from preclinical to commercial stage accelerates market entry by 1-2 years.

Reduce Vein-to-Vein Time
End-to-end automation significantly reduces dwell time compared to manual methods which leads to shorter manufacturing processes.

Improve Process Control
Tight control over all process parameters results in highly reproducible manufacturing results.

Improve Robustness
Eliminating opportunities for operator error and contamination leads to a three-fold reduction in the risk of process failure.
“Cell therapy manufacturing reimagined – advancing automation that focuses on robust and reproducible cell processes that can deliver real cost savings, efficiencies and true scalability.“
Timothy Moore
President & COO, PACT Pharma
Cellares Advisory Board Member
GMP-in-a-Box Cartridge
A closed and single-use cartridge made for automation supports all processing steps from loading the starting material to unloading a cell therapy product ready for infusion.

- Enrichment
- Isolation
- Activation
- Gene Transfer
- Expansion
- Formulation
Supported Applications

90% of Cell Therapy Modalities*

Autologous & Allogeneic Approaches

Centralized & Decentralized Manufacturing
*Cellares Cell Shuttle supports: CAR-T, HSC, TCR, NK, TIL, Treg, γδ T cells
Cellares Software Platform
Modern and intuitive software solution for process design, execution, monitoring, and reporting.

Process Development
High-throughput process optimization studies enable better cell therapy products.

Sampling & Analytics
Automated sampling and QC integration enable deeper understanding and ultimately better cell therapy products.

Electronic Batch Records
Cellares’ software platform has the ability to auto-generate electronic batch records while complying with 21 CFR regulations.